Clinical trial participants: no more study subject, but research partners

Oct 28, 2024 | News

At the Clinical Research As A Care Option (CRAACO) Conference held in Philadelphia on September 16-18, 2024, Nadir Ammour, Global Lead, Clinical Innovation & External Partnerships, Sanofi and co-leader of the FACILITATE project, was the guest speaker in the panel Returning Participant’s Individual Clinical trial Data.

Ammour began his speech by capturing the attention of the audience with the definition of ‘Patient-Centered Research’ as the active, meaningful, and collaborative interaction between patients and researchers at all stages of the research process, where research decision-making is guided by the contribution of patients as partners, recognizing their specific experiences, values, and expertise.

“Patient centricity” stated Ammour “is the commitment to listen and translate patient insights into actions that develop new healthcare solutions with meaningful outcomes, address unmet needs and improve health-related quality of life”.

In terms of shaping research and development programs, patient experience and preference inform benefit risk, identifies outcomes that matter most and support recruitment.

Building on this consideration, Ammour emphasized that clinical trial participants should not be considered “Study subjects” but true “Research partners”.

FACILITATE expected to assist both private and public researchers in navigating the ethical, legal, and science integrity, complexities associated with returning individual clinical trial data to participants.

The European project intends to deliver recommendations and proposed processes so that study participants can access their data in a manner that is both meaningful and respectful of their autonomy. Among its main goals:

  • to develop guidelines for processing and returning study participants data,
  • to propose those guidelines with ethical committees and data protection authorities,
  • to enhance patient willingness to be involved and participate,
  • to inform changes to regulation(s) If needed.

“What is fundamental today” said Ammour in conclusion of his speech “is to emphasize the importance of ongoing dialogue and research in this area and encourage attendees to consider how they can contribute to this important aspect of patient care in their own work”.

Recent news

Opportunities and challenges of person-centric research

Opportunities and challenges of person-centric research

The European project FACILITATE has been showcased at the 10th annual Clinical Monitoring & Patient Recruitment Retention Summit on 20-21 November 2024 in Barcelona, with the topic: Advancing Patient Centric Clinical Trials: the case of IHI FACILITATE, returning...

read more
Let’s FACILITATE Webinar 2024

Let’s FACILITATE Webinar 2024

Understanding the Secondary Use of Clinical Trial Data: perspectives from patients, clinicians, industry, and regulators We are delighted to invite you to the II LET’s FACILITATE 2024 Webinar, an engaging exploration and roundtable discussion centered around the...

read more
An ethical-legal framework built on social alliance

An ethical-legal framework built on social alliance

At the 42nd National Congress of the Italian Society of Pharmacology, which was held in Sorrento, Italy, November 13-16, 2024, Veronica Rivi, from the Department of Biomedical, Metabolic and Neuroscience Sciences at UNIMORE and a member of FACILITATE, presented a...

read more

Join our POOL OF STAKEHOLDERS!

Do you want to receive our updates, access information on our activities and events and be in contact with our project?

Latest News

Upcoming Events

Report